Roflumilast
NDC 0904-7493, Roflumilast, tablet, from MAJOR PHARMACEUTICALS.
- Product NDC
- 0904-7493
- Status
- Listed
- Labeler
- MAJOR PHARMACEUTICALS
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208256
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0904-7493 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROFLUMILAST250 ug/1
Pharmacologic classes
Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0904-7493-71 | 00904749371 | 28 TABLET in 1 BOTTLE (0904-7493-71) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c51b80f3-a591-4db9-81b4-b91603e35d7cNADAC price for package 00904749371
GET /v1/drugs/nadac/00904749371
Use it
Look up 0904-7493 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0904-7493 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0904-7493. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.